PlantEXT is an IsraeliCanadian company discovering and developing active cannabis extracts with a focus on anti-inflammatory remedies.

PlantEXT's technology isolates therapeutic elements at the molecular level and quantifies anti-inflammatory activity through in-vitro and ex-vivo studies.

The company's team has developed a pipeline of anti-inflammatory products supported by pre-clinical and clinical research.

The company is currently launching its first line of IBD medical cannabis products in Israel and will follow with its international expansion and the launch of further medical products for additional indications such as psoriasis, atopic dermatitis, arthritis, pain, and migraines.The company has a research agreement with the agricultural research organization Volcani Center and the exclusive rights to commercialize the results and products worldwide.